Items where the Publication is Clinical pharmacology and therapeutics
Number of items: 11.
2023
  • Facilitating Next-Generation Pre-Exposure Prophylaxis Clinical Trials Using HIV Recent Infection Assays: A Consensus Statement from the Forum HIV Prevention Trial Design Project. (2023) Parkin, Neil; Gao, Fei; Grebe, Eduard; Cutrell, Amy; Das, Moupali; Donnell, Deborah; Duerr, Ann; Glidden, David V; Hughes, James P; Murray, Jeffrey; Robertson, Michael N; Zinserling, Joerg; Lau, Joseph; Miller, Veronica; Forum for Collaborative Research Recency Assay Working Group
  • Prognostic Factors of COVID-19: An Umbrella Review Endorsed by the International Society for Pharmacoepidemiology. (2023) Sarri, Grammati; Liu, Wei; Zabotka, Luke; Freitag, Andreas; Claire, Ravinder; Wangge, Grace; Elvidge, Jamie; Dawoud, Dalia; Bennett, Dimitri; Wen, Xuerong; Li, Xiaojuan; Rentsch, Christopher T; Uddin, Md Jamal; Ali, M Sanni; Gokhale, Mugdha; Déruaz-Luyet, Anouk; Moga, Daniela C; Guo, Jeff Jianfei; Zullo, Andrew R; Patorno, Elisabetta; Lin, Kueiyu Joshua
    • 2022
  • Mechanistic Modeling of Primaquine Pharmacokinetics, Gametocytocidal Activity, and Mosquito Infectivity. (2022) Chotsiri, Palang; Mahamar, Almahamoudou; Hoglund, Richard M; Koita, Fanta; Sanogo, Koualy; Diawara, Halimatou; Dicko, Alassane; Simpson, Julie A; Bousema, Teun; White, Nicholas J; Brown, Joelle M; Gosling, Roly; Chen, Ingrid; Tarning, Joel
  • ISPE-Endorsed Guidance in Using Electronic Health Records for Comparative Effectiveness Research in COVID-19: Opportunities and Trade-Offs. (2022) Sarri, Grammati; Bennett, Dimitri; Debray, Thomas; Deruaz-Luyet, Anouk; Soriano Gabarró, Montse; Largent, Joan A; Li, Xiaojuan; Liu, Wei; Lund, Jennifer L; Moga, Daniela C; Gokhale, Mugdha; Rentsch, Christopher T; Wen, Xuerong; Yanover, Chen; Ye, Yizhou; Yun, Huifeng; Zullo, Andrew R; Lin, Kueiyu Joshua
    • 2018
  • Real-World Evidence: What It Is and What It Can Tell Us According to the International Society for Pharmacoepidemiology (ISPE) Comparative Effectiveness Research (CER) Special Interest Group (SIG). (2018) Yuan, Hongbo; Ali, M Sanni; Brouwer, Emily S; Girman, Cynthia J; Guo, Jeff J; Lund, Jennifer L; Patorno, Elisabetta; Slaughter, Jonathan L; Wen, Xuerong; Bennett, Dimitri; ISPE Comparative Effectiveness Research Special Interest Group
    • 2013
  • Population pharmacokinetics of intramuscular artesunate in African children with severe malaria: implications for a practical dosing regimen. (2013) Hendriksen, ICE; Mtove, G; Kent, A; Gesase, S; Reyburn, H; Lemnge, MM; Lindegardh, N; Day, NPJ; von Seidlein, L; White, NJ; Dondorp, AM; Tarning, J
    • 2012
  • Advances in imaging to support the development of novel therapies for multiple sclerosis. (2012) Miller, DH; Altmann, DR; Chard, DT
    • 2011
  • Phenotype standardization for immune-mediated drug-induced skin injury. (2011) Pirmohamed, M; Friedmann, PS; Molokhia, M; Loke, YK; Smith, C; Phillips, E; La Grenade, L; Carleton, B; Papaluca-Amati, M; Demoly, P; Shear, NH
  • Comparison of Six Commonly Used Qt Correction Formulae and Three Parameter Estimation Methods. (2011) Taubel, J; Wang, D; Naseem, A; Arizena, R; Camm, AJ
    • 2007
  • Novel statistical tools for monitoring the safety of marketed drugs. (2007) Almenoff, JS; Pattishall, EN; Gibbs, TG; DuMouchel, W; Evans, SJW; Yuen, N
    • 2006
  • MDR1 gene polymorphisms are associated with neuropsychiatric adverse effects of mefloquine. (2006) Aarnoudse, Albert LHJ; van Schaik, Ron HN; Dieleman, Jeanne; Molokhia, Mariam; van Riemsdijk, Melanie M; Ligthelm, Robert J; Overbosch, David; van der Heiden, Ilse P; Stricker, Bruno H Ch